CAPRICOR THERAPEUTICS, INC. Interest Payable
CAPRICOR THERAPEUTICS, INC. (CAPR) had Interest Payable of $0 as of 2017-12-31, per its 10-K filed 2018-03-22.
Discontinued › Balance Sheet › Liabilities › Accrued Liabilities
us-gaap:InterestPayableCurrentAndNoncurrent · last filed 2018-03-22
- 2017-12-31: Interest Payable $0.00.
- 2017-09-30: Interest Payable $0.00.
- 2017-06-30: Interest Payable $1.06M.
- 2017-03-31: Interest Payable $954.79K.
| Period end | Interest Payable |
|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-03-22 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-14 |
| 2017-06-30 | $1.06M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $954.79K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $849.47K 10-K · filed 2018-03-22 |
| 2016-09-30 | $746.56K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $647.82K 10-Q · filed 2016-08-15 |
| 2016-03-31 | $571.15K 10-Q · filed 2016-05-13 |
| 2015-12-31 | $505.36K 10-K · filed 2017-03-16 |
| 2015-09-30 | $443.68K 10-Q · filed 2015-11-13 |
| 2015-06-30 | $382.00K 10-Q · filed 2015-08-14 |
| 2015-03-31 | $320.35K 10-Q · filed 2015-05-13 |
| 2014-12-31 | $258.64K 10-K · filed 2016-03-30 |
| 2014-09-30 | $198.26K 10-Q · filed 2014-11-14 |
| 2014-06-30 | $138.16K 10-Q · filed 2014-08-14 |
| 2013-12-31 | $58.13K 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |